International Collaborations

World Map

Cancer is a global challenge, and one that we must all fight. Research performed in the laboratories and clinics in Manchester has an impact across the world. We have, and continue to, forge and foster collaborations with research institutions and businesses to help realise our vision.

To that end, our researchers and scientists know that the expertise and facilities available to researchers in Manchester can prove vital in the fight against this disease. We’re incredibly proud of the collaborations we have developed over the past several decades.

 

Improving the outcomes of childhood leukaemia in India

Faced with the challenge of how to improve the outcomes of children affected by Acute Lymphoblastic Leukaemia (ALL) in India, Professor Vaskar Saha sought to bring the lessons, systems and processes from Manchester and implement them into the health systems in the East.

 

As part of an over five-year project, Professor Saha has used his years of experience in laboratory technology to standardise treatments and processes and establish an equitable standardised healthcare system that provides treatments and financial support to families affected by the disease. As a result of his work, survival rates increased from 65% in 2014 to 80% in 2019, and also helped establish systems for more people to access the healthcare they needed.

Professor Vaskar Saha, Professor of Paediatric Oncology at The University of Manchester

Professor Vaskar Saha took on the challenge of improving Acute Lymphoblastic Leukaemia (ALL) survival rates in children in India. Read his story in this University of Manchester Magazine feature from 2019.

Collaborating with the US to improve Early Detection research

It has long been recognised that early detection and diagnosis of cancer is linked to improved outcomes and longer survival. The creation of the International Alliance for Cancer Early Detection (ACED) by Cancer Research UK in 2019 represents this importance as this put early detection and international collaboration at the forefront of discovery.

 

ACED represents a partnership between Cancer Research UK and five research institutions in the UK and US: the University of Cambridge, UCL, the University of Manchester, Oregon Health and Science University and The Canary Center at Stanford University.

 

Together, our researchers are collaborating to build capacity for new research collaborations, share expertise and common practice in early detection science, and train the next generation of early detection scientists.

 

Find out more about the research projects in Manchester on the ACED Manchester website.

Cross-Disciplinary Research

Discover how cross-discipline teams with complementary experience and expertise are collectively working on solutions to some of the most challenging cancer challenges.

Working with Industry

Discover how we are working with industry to develop and commercialise novel…